166 related articles for article (PubMed ID: 1670251)
1. [Sweet's syndrome associated with accelerated phase (blast crisis) of chronic myeloid leukemia].
Elovaara E; Kariniemi AL; Somer T
Duodecim; 1990; 106(8):630-4. PubMed ID: 1670251
[No Abstract] [Full Text] [Related]
2. Neutrophilic dermatoses associated with myeloid malignancy.
Cho KH; Han KH; Kim SW; Youn SW; Youn JI; Kim BK
Clin Exp Dermatol; 1997 Nov; 22(6):269-73. PubMed ID: 9604452
[TBL] [Abstract][Full Text] [Related]
3. [Causes of death in chronic myeloid leukemia. Analysis of 109 patients].
Cervantes F; Sanz C; Bosch F; Rozman C
Sangre (Barc); 1991 Jun; 36(3):183-6. PubMed ID: 1948535
[TBL] [Abstract][Full Text] [Related]
4. Sweet's syndrome after splenic irradiation for chronic myelogenous leukemia.
Pertusi RM; Forman MD; Brown AC
J Am Osteopath Assoc; 1996 Jun; 96(6):366-7. PubMed ID: 8690626
[TBL] [Abstract][Full Text] [Related]
5. Sweet's syndrome and accelerated phase of chronic myelogenous leukemia.
Fernández-Jiménez MC; Herraez R; Ojeda E; Hernández-Navarro F
Ann Hematol; 2000 Oct; 79(10):585-7. PubMed ID: 11100752
[TBL] [Abstract][Full Text] [Related]
6. Concurrent Sweet's syndrome and leukemia cutis in patients with myeloid disorders.
del Pozo J; Martínez W; Pazos JM; Yebra-Pimentel MT; García Silva J; Fonseca E
Int J Dermatol; 2005 Aug; 44(8):677-80. PubMed ID: 16101872
[TBL] [Abstract][Full Text] [Related]
7. Case records of the Department of Medicine University of Mississippi Medical Center. Sweet's syndrome (acute febrile neutrophilic dermatosis).
Adkins T; Rees M; Simeone F; Finley R; Launey D; Peace R; Johnson W
J Miss State Med Assoc; 1994 Jan; 35(1):7-11. PubMed ID: 8164269
[No Abstract] [Full Text] [Related]
8. The plicamycin and hydroxyurea combination chemotherapy for chronic granulocytic leukemia in myeloid transformation.
Antimi M; Masi M; Delannoy A; Ferrant A; Doyen C; Debusscher L; Delwiche F; Stryckmans P; Papa G
Haematologica; 1990; 75(5):443-6. PubMed ID: 2151448
[TBL] [Abstract][Full Text] [Related]
9. [Fever and pustular cutaneous eruptions in a 45-year old woman with chronic myeloid leukemia].
Sánchez-Yus E; Palou J
Med Clin (Barc); 1992 Mar; 98(10):389-96. PubMed ID: 1564973
[No Abstract] [Full Text] [Related]
10. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].
Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Mori H; Niikura H; Omine M; Fujita K
Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272
[TBL] [Abstract][Full Text] [Related]
11. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
12. Advances in prognosis of chronic myeloid leukemia.
Baccarani M; Russo D; Fanin R; Zuffa E; Tura S
Haematologica; 1992; 77(5):377-80. PubMed ID: 1483586
[No Abstract] [Full Text] [Related]
13. [Pyoderma gangrenosum and Sweet's syndrome in a case of chronic myeloid leukemia].
Diéguez JC; Fernández Jurado A; Rodríguez JN; Pérez Vega D; Prados D
Sangre (Barc); 1993 Jun; 38(3):247-8. PubMed ID: 8211554
[No Abstract] [Full Text] [Related]
14. Sweet's syndrome with myelofibrosis and leukemia: partial response to interferon.
Brodkin RH; Schwartz RA
Dermatology; 1995; 190(2):160-3. PubMed ID: 7727840
[TBL] [Abstract][Full Text] [Related]
15. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
16. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
[TBL] [Abstract][Full Text] [Related]
17. Neutrophilic pustulosis associated with chronic myeloid leukemia: a special form of Sweet's syndrome. Report of two cases.
Feliu E; Cervantes F; Ferrando J; Puig S; Mascaro JM; Rozman C
Acta Haematol; 1992; 88(2-3):154-7. PubMed ID: 1466198
[TBL] [Abstract][Full Text] [Related]
18. Histiocytoid Sweet's syndrome associated with t(9;22)(q34;q11)-positive chronic myelogenous leukemia: immature granulocytic origin of histiocytic cells.
Kasuya A; Fujiyama T; Hashizume H; Inuzuka M; Tokura Y
Int J Dermatol; 2013 Dec; 52(12):1577-9. PubMed ID: 24261731
[No Abstract] [Full Text] [Related]
19. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
20. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
